HUMAN INHIBITORS FROM SEVERE VON-WILLEBRAND DISEASE PATIENTS INHIBIT VON-WILLEBRAND-FACTOR BINDING TO COLLAGEN

被引:0
|
作者
BATLLE, J
BOSCH, N
CASTILLO, R
MONTEAGUDO, J
LOPEZ, MJB
FERNANDEZ, MFL
机构
[1] HOSP JUAN CANALEJO TERESA HERRERA, SERV HEMATOL & HEMOTERAPIA, LA CORUNA, SPAIN
[2] BANCO MUNICIPAL SANGRE, CARACAS, VENEZUELA
[3] HOSP CLIN BARCELONA, SERV HEMOSTASIA & HEMOTERAPIA, BARCELONA 36, SPAIN
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1182 / 1182
页数:1
相关论文
共 50 条
  • [11] THE VON-WILLEBRAND-FACTOR PROPOLYPEPTIDE (VWAGII) AS A MARKER OF ACQUIRED VON-WILLEBRAND SYNDROME
    SCOTT, JP
    VOKAC, E
    FOSTER, PA
    KASAY, K
    MONTGOMERY, RR
    BLOOD, 1993, 82 (10) : A150 - A150
  • [12] MUTATIONS OF VON-WILLEBRAND-FACTOR GENE IN FAMILIES WITH VON-WILLEBRAND DISEASE IN THE ALAND-ISLANDS
    ZHANG, ZP
    BLOMBACK, M
    NYMAN, D
    ANVRET, M
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (17) : 7937 - 7940
  • [13] PROTEOLYTIC PROCESSING OF VON-WILLEBRAND-FACTOR SUBUNIT - HETEROGENEITY IN TYPE-IIA VON-WILLEBRAND DISEASE
    BATLLE, J
    LASIERRA, J
    VILLAMOR, AF
    NAVARRO, JL
    PARDO, A
    CAMPOS, M
    JUSTICA, B
    FERNANDEZ, MFL
    ANNALS OF HEMATOLOGY, 1994, 68 (03) : 111 - 115
  • [14] PROTEOLYTIC PROCESSING OF VON-WILLEBRAND-FACTOR SUBUNIT - HETEROGENEITY IN TYPE-IIA VON-WILLEBRAND DISEASE
    BATLLE, J
    LASIERRA, J
    VILLAMOR, AF
    NAVARRO, JL
    PARDO, A
    CAMPOS, M
    JUSTICA, B
    FERNANDEZ, MFL
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 1182 - 1182
  • [15] VON-WILLEBRAND DISEASE IN THE RIIIS/J MOUSE IS CAUSED BY A DEFECT OUTSIDE OF THE VON-WILLEBRAND-FACTOR GENE
    NICHOLS, WC
    COONEY, KA
    MOHLKE, KL
    BALLEW, JD
    YANG, A
    BRUCK, ME
    REDDINGTON, M
    NOVAK, EK
    SWANK, RT
    GINSBURG, D
    BLOOD, 1994, 83 (11) : 3225 - 3231
  • [16] RATE OF SYNTHESIS OF FACTOR-VIII AND DECAY OF FACTOR-VIII AND VON-WILLEBRAND-FACTOR (VWF) IN SEVERE VON-WILLEBRAND DISEASE (VWD)
    MENACHE, D
    ARONSON, DL
    DARR, F
    MONTGOMERY, RR
    BLOOD, 1994, 84 (10) : A238 - A238
  • [17] HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN DELAYS CLEARANCE OF VON-WILLEBRAND-FACTOR IN ACQUIRED VON-WILLEBRAND DISEASE
    VANGENDEREN, PJJ
    TERPSTRA, W
    MICHIELS, JJ
    KAPTEIJN, L
    VANVLIET, HHDM
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (05) : 891 - 892
  • [18] ACQUIRED VON-WILLEBRAND DISEASE-ASSOCIATED WITH MULTIPLE-MYELOMA - CHARACTERIZATION OF AN INHIBITOR TO VON-WILLEBRAND-FACTOR
    MOHRI, H
    TANABE, J
    OHTSUKA, M
    YOSHIDA, M
    MOTOMURA, S
    NISHIDA, S
    FUJIMURA, Y
    OKUBO, T
    BLOOD COAGULATION & FIBRINOLYSIS, 1995, 6 (06) : 561 - 566
  • [19] INTERPLAY OF VON-WILLEBRAND-FACTOR (VWF) MUTATIONS ON GPIB-BINDING AND F-VIII-BINDING VARIANTS OF VON-WILLEBRAND DISEASE (VWD)
    ROCK, AL
    KRONER, PA
    FAHS, S
    KLUESSENDORF, M
    FRIEDMAN, KD
    MONTGOMERY, RR
    BLOOD, 1993, 82 (10) : A339 - A339
  • [20] MUTATION SCREENING OF THE VON-WILLEBRAND-FACTOR GENE IN VON-WILLEBRAND DISEASE TYPE-I AND TYPE-III PATIENTS
    ZHANG, ZP
    FALK, G
    EGBERG, N
    BLOMBACK, M
    ANVRET, M
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 1179 - 1179